Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Citadel Group M&A Activity 2021

Jan 20, 2021

10454_mrq_2021-01-20_3222898b-7d15-4333-8408-16e5c830bd94.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3496M

Citadel Group

20 January 2021

Ap 19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.         KEY INFORMATION

Name of person dealing (Note 1) Citadel Group
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note 2) Common Stock ISIN IE00BDB6Q211
Date of dealing 19 January, 2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security

dealt in (Note 3)

Long Short
ISIN IE00BDB6Q211 Number        (%) Number      (%)
(1) Relevant securities 183,410 (0.14%) 1,192 (0.00%)
(2) Derivatives (other than options) 1,129,135 (0.88%) 0 (0.00%)
(3) Options and agreements to purchase/sell 0 (0.00%) 0 (0.00%)
Total 1,312,545 (1.02%) 1,192 (0.00%)

Ap 20

1.         DEALINGS (Note 4)

(a)        Purchases and sales

Purchase/sale

ISIN IE00BDB6Q211
Number of securities Price per unit (Note 5)
Buy Transaction 223 206.6379 USD
Buy Transaction 119 206.8582 USD
Buy Transaction 100 206.9000 USD
Buy Transaction 73 207.1700 USD
Buy Transaction 209 207.5483 USD
Buy Transaction 312 207.6980 USD
Buy Transaction 524 207.6984 USD
Buy Transaction 164 207.7656 USD
Buy Transaction 1,287 207.9446 USD
Buy Transaction 498 208.1953 USD
Buy Transaction 8 208.2800 USD
Buy Transaction 112 208.4118 USD
Buy Transaction 1,520 208.5000 USD
Buy Transaction 78 208.5000 USD
Buy Transaction 16 208.7700 USD
Buy Transaction 8 208.9100 USD
Buy Transaction 1 208.9100 USD
Sell Transaction 1,841 206.7488 USD
Sell Transaction 46 206.8900 USD
Sell Transaction 100 207.0600 USD
Sell Transaction 382 207.3539 USD
Sell Transaction 93 207.6800 USD
Sell Transaction 139 207.7500 USD
Sell Transaction 702 207.7882 USD
Sell Transaction 205 207.8727 USD
Sell Transaction 1,812 207.8996 USD
Sell Transaction 766 208.0248 USD
Sell Transaction 876 208.0872 USD
Sell Transaction 19 208.3647 USD
Sell Transaction 185 208.3800 USD
Sell Transaction 934 208.5000 USD
Sell Transaction 23 208.7700 USD
Sell Transaction 1 208.8100 USD
Sell Transaction 88 209.0000 USD
Sell Transaction 73 209.0500 USD

(b)        Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

ISIN IE00BDB6Q211
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)
CFD Reducing long position 29,281 208.6856 USD
CFD Reducing long position 35,000 207.7865 USD
CFD Reducing long position 3,159 208.3542 USD

(c)        Options transactions in respect of existing relevant securities

(i)         Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing,

varying etc.
Number of securities to which the option relates (Note 7) Exercise price Type,

e.g. American, European etc.
Expiry date Option money paid/ received per unit

(Note 5)

(ii)        Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit

(Note 5)

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

      (if applicable) (Note 5)

Ap 21

2.         OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None

Is a Supplemental Form 8 attached? (Note 9)

NO

Date of disclosure: 20 January, 2021
Contact name: Kim Heslop
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEEADFEAFDFEFA